Emerging Infection with Elizabethkingia meningoseptica in Neonate. A Case Report

1. Bhat KS, Priya R, Krishnan L, Kanungo R. Elizabethkingia meningoseptica bacteremia in a neonate: A case report and mini-review of the literature. J Curr Res Sci Med. 2016;2:42-5.10.4103/2455-3069.184130Search in Google Scholar

2. Oren A, da Costa MS, Garrity GM, et al. Proposal to include the rank of phylum in the international code of nomenclature of prokaryotes. Int J Syst Evol Microbiol. 2015;65:4284–7.10.1099/ijsem.0.00066426654112Search in Google Scholar

3. Kim KK, Kim MK, Lim JH, Park HY, Lee ST. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. Int J Syst Evol Microbiol. 2005;55(Pt 3):1287–93.10.1099/ijs.0.63541-015879269Search in Google Scholar

4. Breurec S, Criscuolo A, Diancourt L, et al. Genomic epidemiology and global diversity of the emerging bacterial pathogen Elizabethkingia anophelis. Sci Rep. 2016, 6:30379.10.1038/srep30379496196327461509Search in Google Scholar

5. Chen S, Soehnlen M, Downes FP, Walker ED. Insights from the draft genome into the pathogenicity of a clinical isolate of Elizabethkingia meningoseptica Em3. Stand Genom Sci. 2017;12:56.10.1186/s40793-017-0269-8560293128932346Search in Google Scholar

6. Jean SS, Lee WS, Chen FL, Ou TY, Hsueh PR. Elizabethkingia meningoseptica: an important emerging pathogen causing healthcare-associated infections. J Hosp Infect. 2014;86(4):244–9.10.1016/j.jhin.2014.01.00924680187Search in Google Scholar

7. Pereira GH, Garcia DO, Abboud CS, Barbosa VLB, da PSL S. Nosocomial infections caused by Elizabethkingia meningoseptica: an emergent pathogen. Braz J Infect Dis. 2013;17:606–9.10.1016/j.bjid.2013.02.01124055393Search in Google Scholar

8. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.Search in Google Scholar

9. Eriksen HB, Gumpert H, Faurholt CH, Westh H. Determination of Elizabethkingia Diversity by MALDI-TOF Mass Spectrometry and Whole-Genome Sequencing. Emerg Infect Dis. 2017;23(2):320-3.10.3201/eid2302.161321532480828098550Search in Google Scholar

10. Hsu MS, Liao CH, Huang YT, et al. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999–2006. Eur J Clin Microbiol Infect Dis. 2011;30(10):1271–8.10.1007/s10096-011-1223-021461847Search in Google Scholar

11. Lin PY, Chen HL, Huang CT, Su LH, Chiu CH. Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia. Int J Antimicrob Agents. 2010;36:436–40.10.1016/j.ijantimicag.2010.06.03320933186Search in Google Scholar

12. van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: Diagnosis and treatment of acute bacterial meningitis for the ESCMID Study Group for Infections of the Brain (ESGIB). Clin Microbiol Infect. 2016;22:S37-S62.10.1016/j.cmi.2016.01.00727062097Search in Google Scholar

13. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice Guidelines for Bacterial Meningitis. Clin Infect Dis. 2004;39:1267-84.10.1086/42536815494903Search in Google Scholar

14. Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23(3):467–92.10.1128/CMR.00070-09290165620610819Search in Google Scholar

15. Hsu MS, Liao CH, Huang YT, et al. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999–2006. Eur J Clin Microbiol Infect Dis. 2011;30(10):1271–8.10.1007/s10096-011-1223-021461847Search in Google Scholar

16. Ceyhan M, Celik M. Elizabethkingia meningosepticum (Chryseobacterium meningosepticum) Infections in Children. Int J Pediatr. 2011:215-37.10.1155/2011/215237319918522046191Search in Google Scholar

17. Shah Z, Soodhana D, Kalathia M, Parikh Y. Elizabethkingia meningoseptica: an emerging threat. Int J Contemp Pediatr. 2017;4(5):1909-10.10.18203/2349-3291.ijcp20173810Search in Google Scholar

18. Kavuncuoglu S, Gursoy S, Turel O, Aldemir EY, Hosaf E. Neonatal bacterial meningitis in Turkey: epidemiology, risk factors, and prognosis. J Infect Dev Ctries. 2013;7(2):73–81.10.3855/jidc.265223416652Search in Google Scholar

19. Lin PY, Chu C, Su LH, Huang CT, Chang WY, Chiu CH. Clinical and microbiological analysis of bloodstream infections caused by Chryseobacterium meningo-septicum in nonneonatal patients. J Clin Microbiol. 2004;42(7):3353–5.10.1128/JCM.42.7.3353-3355.200444630715243115Search in Google Scholar

20. Shinha T, Ahuja R. Bacteremia due to Elizabethkingia meningoseptica. IDcases. 2015;2(1):13-5.10.1016/j.idcr.2015.01.002467262026793448Search in Google Scholar

21. Issack MI, Neetoo Y. An outbreak of Elizabethkingia meningoseptica neonatal meningitis in Mauritius. J Infect Dev Ctries. 2011;5(12):834–39.10.3855/jidc.188522169781Search in Google Scholar

22. Huang YC, Lin YT, Wang FD. Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia. Int J Antimicrob Agents. 2018;51(1):47-51.10.1016/j.ijantimicag.2017.05.01828668676Search in Google Scholar

23. Vincent JL, Bassetti M, Francois B, et al. Advances in antibiotic therapy in the critically ill. Crit Care. 2016; 20:133.10.1186/s13054-016-1285-6486933227184564Search in Google Scholar

24. Neuner EA, Ahrens CL, Groszek JJ, et al. Use of therapeutic drug monitoring to treat Elizabethkingia meningoseptica meningitis and bacteraemia in an adult. J Antimicrob Chemother. 2012;67:1558–60.10.1093/jac/dks053335032822357803Search in Google Scholar

25. Newby BD, Timberlake KE, Lepp LM, Mihic T, Dersch-Mills DA. Levofloxacin Use in the Neonate: A Case Series. JPPT. 2017;22(4):304-13.10.5863/1551-6776-22.4.304556221228943827Search in Google Scholar

26. Bruun B, Tversrupjensen E, Lundstrom K, Andersen GE. The C meningosepticum infection in a Neonatal ward. Eur J Clin Microbiol Infect Dis. 1989;816:509-14.10.1007/BF019674692504590Search in Google Scholar

27. Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore), 1997;76: 30-41.10.1097/00005792-199701000-000039064486Search in Google Scholar